myTomorrows is a global health tech company focused on improving patient access to treatment options. By leveraging advanced AI technology, myTomorrows connects patients, healthcare professionals, and Biopharma companies to facilitate earlier and better treatment access. The company operates in 125 countries and has successfully supported over 14,000 patients and 2,200 physicians, earning the trust of more than 50 Biopharma companies. Their services include clinical trial patient recruitment, Expanded Access Program management, and Real-World Data collection, all aimed at making tomorrow's therapies accessible today.